Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 197

1.

Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: results from the WELCOME trial.

Scorletti E, West AL, Bhatia L, Hoile SP, McCormick KG, Burdge GC, Lillycrop KA, Clough GF, Calder PC, Byrne CD.

J Hepatol. 2015 Aug 10. pii: S0168-8278(15)00539-5. doi: 10.1016/j.jhep.2015.07.036. [Epub ahead of print]

PMID:
26272871
2.

Glycaemic control and lipid concentrations in a cohort of people with diabetes over 7 years of follow-up: a regional audit of diabetes care in the UK.

Wainwright P, Oluwatowoju I, Ryan A, Abu E, Byrne CD.

Diabet Med. 2015 Jul 14. doi: 10.1111/dme.12853. [Epub ahead of print]

PMID:
26172344
3.

γ-Glutamyl Transferase Is Associated with Mortality Outcomes Independently of Fatty Liver.

Sung KC, Ryu S, Kim BS, Cheong ES, Park DI, Kim BI, Kwon MJ, Wild SH, Byrne CD.

Clin Chem. 2015 Jul 7. pii: clinchem.2015.240424. [Epub ahead of print]

PMID:
26152752
4.

Importance of early recognition of heterozygous familial hypercholesterolaemia.

Ryan A, Byrne CD.

Curr Opin Lipidol. 2015 Aug;26(4):298-303. doi: 10.1097/MOL.0000000000000196.

PMID:
26103611
5.

All-Cause and Cardiovascular Mortality Among Koreans: Effects of Obesity and Metabolic Health.

Sung KC, Ryu S, Cheong ES, Kim BS, Kim BJ, Kim YB, Chung PW, Wild SH, Byrne CD.

Am J Prev Med. 2015 Jul;49(1):62-71. doi: 10.1016/j.amepre.2015.02.010.

PMID:
26094228
6.

Impact of high dose n-3 polyunsaturated fatty acid treatment on measures of microvascular function and vibration perception in non-alcoholic fatty liver disease: results from the randomised WELCOME trial.

McCormick KG, Scorletti E, Bhatia L, Calder PC, Griffin MJ, Clough GF, Byrne CD.

Diabetologia. 2015 Aug;58(8):1916-25. doi: 10.1007/s00125-015-3628-2. Epub 2015 May 29.

PMID:
26021488
7.

Increased Cardiovascular Mortality in Subjects With Metabolic Syndrome Is Largely Attributable to Diabetes and Hypertension in 159 971 Korean Adults.

Sung KC, Rhee EJ, Ryu S, Kim BJ, Kim BS, Lee WY, Oh KW, Kim YB, Chung PW, Kim H, Byrne CD, Lee KB, Park SW.

J Clin Endocrinol Metab. 2015 Jul;100(7):2606-12. doi: 10.1210/jc.2014-4031. Epub 2015 May 20.

PMID:
25993638
8.

Circulating Markers of Liver Function and Cardiovascular Disease Risk.

Targher G, Byrne CD.

Arterioscler Thromb Vasc Biol. 2015 May 14. pii: ATVBAHA.115.305235. [Epub ahead of print]

PMID:
25977566
9.

Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease.

Mantovani A, Pernigo M, Bergamini C, Bonapace S, Lipari P, Valbusa F, Bertolini L, Zenari L, Pichiri I, Dauriz M, Zoppini G, Barbieri E, Byrne CD, Bonora E, Targher G.

Metabolism. 2015 Aug;64(8):879-87. doi: 10.1016/j.metabol.2015.04.003. Epub 2015 May 1.

PMID:
25957758
10.

NAFLD: a multisystem disease.

Byrne CD, Targher G.

J Hepatol. 2015 Apr;62(1 Suppl):S47-64. doi: 10.1016/j.jhep.2014.12.012. Review.

11.

A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.

Targher G, Byrne CD.

Metab Syndr Relat Disord. 2015 Aug;13(6):235-8. doi: 10.1089/met.2015.1502. Epub 2015 Feb 25.

PMID:
25714786
12.

An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality.

Sung KC, Ryu S, Wild SH, Byrne CD.

Heart. 2015 Apr;101(7):553-8. doi: 10.1136/heartjnl-2014-306784. Epub 2015 Jan 30.

PMID:
25637367
13.

Composition of dietary macronutrient intake is not associated with prevalence of coronary artery calcification in healthy Korean adults.

Sung KC, Sung E, Byrne CD, Kim YB, Ahn CW, Chung HK.

Ann Nutr Metab. 2015;66(1):36-43. doi: 10.1159/000369563. Epub 2014 Dec 13.

PMID:
25531976
14.

The reduced cost of providing a nationally recognised service for familial hypercholesterolaemia.

Pears R, Griffin M, Watson M, Wheeler R, Hilder D, Meeson B, Bacon S, Byrne CD.

Open Heart. 2014 Aug 12;1(1):e000015. doi: 10.1136/openhrt-2013-000015. eCollection 2014.

15.

Application of new guidelines for the primary prevention of atherosclerotic cardiovascular disease in a Korean population.

Kim NH, So MS, Kang JG, Cho DS, Byrne CD, Lee SJ, Sung KC.

J Atheroscler Thromb. 2015;22(3):293-303. doi: 10.5551/jat.26682. Epub 2014 Oct 4.

16.

Evaluation of bioelectrical impedance analysis for identifying overweight individuals at increased cardiometabolic risk: a cross-sectional study.

Lamb MJ, Byrne CD, Wilson JF, Wild SH.

PLoS One. 2014 Sep 22;9(9):e106134. doi: 10.1371/journal.pone.0106134. eCollection 2014.

17.

CKD and nonalcoholic fatty liver disease.

Targher G, Chonchol MB, Byrne CD.

Am J Kidney Dis. 2014 Oct;64(4):638-52. doi: 10.1053/j.ajkd.2014.05.019. Epub 2014 Jul 30. Review.

PMID:
25085644
18.

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.

Scorletti E, Bhatia L, McCormick KG, Clough GF, Nash K, Hodson L, Moyses HE, Calder PC, Byrne CD; WELCOME Study.

Hepatology. 2014 Oct;60(4):1211-21.

PMID:
25043514
19.

Randomised controlled feasibility trial of a web-based weight management intervention with nurse support for obese patients in primary care.

Yardley L, Ware LJ, Smith ER, Williams S, Bradbury KJ, Arden-Close EJ, Mullee MA, Moore MV, Peacock JL, Lean ME, Margetts BM, Byrne CD, Hobbs RF, Little P.

Int J Behav Nutr Phys Act. 2014 May 21;11:67. doi: 10.1186/1479-5868-11-67.

20.

Daily energy expenditure, cardiorespiratory fitness and glycaemic control in people with type 1 diabetes.

Valletta JJ, Chipperfield AJ, Clough GF, Byrne CD.

PLoS One. 2014 May 14;9(5):e97534. doi: 10.1371/journal.pone.0097534. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk